Exane Derivatives Las Vegas Sands Corp Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Las Vegas Sands Corp stock. As of the latest transaction made, Exane Derivatives holds 9 shares of LVS stock, worth $458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 1,827
99.51%
Holding current value
$458
Previous $71,000
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding LVS
# of Institutions
718Shares Held
324MCall Options Held
19.9MPut Options Held
11.8M-
Capital Research Global Investors Los Angeles, CA46.5MShares$2.37 Billion0.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA42.3MShares$2.16 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY28MShares$1.43 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD15.4MShares$786 Million0.09% of portfolio
-
State Street Corp Boston, MA14.9MShares$761 Million0.03% of portfolio
About LAS VEGAS SANDS CORP
- Ticker LVS
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Resorts & Casinos
- Shares Outstandng 764,166,016
- Market Cap $38.9B
- Description
- Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, the Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, Cotai Strip, and the Sands Macao in Macao, the People's Republic of China...